Pleural Effusion, Malignant Clinical Trials
3 recruiting trials for Pleural Effusion, Malignant. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
The primary objective of this study, sponsored by Travera Inc. in Massachusetts, is to validate whether the mass response biomarker has potential to predict response of patients...
Sponsor: Travera IncEnrolling: 2001 location
RECRUITINGPhase 1NCT07192900
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
This research study aims to evaluate the safety and effectiveness of a novel immunotherapy, Fast TIL, an Adoptive Cellular Therapeutic (ACT), to fight cancer that has spread to...
Sponsor: David Bartlett, MDEnrolling: 101 location
RECRUITINGNCT06946498
First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
Non randomized study with two groups. The study group includes patients with suspected malignant pleural effusion, in whom the investigation of pleural effusion begins directly...
Sponsor: National and Kapodistrian University of AthensEnrolling: 1001 location